214 related articles for article (PubMed ID: 7558330)
1. Chronic respiratory mycoplasmosis in C3H/HeN and C57BL/6N mice: lesion severity and antibody response.
Cartner SC; Simecka JW; Lindsey JR; Cassell GH; Davis JK
Infect Immun; 1995 Oct; 63(10):4138-42. PubMed ID: 7558330
[TBL] [Abstract][Full Text] [Related]
2. Pulmonary clearance of Mycoplasma pulmonis in C57BL/6N and C3H/HeN mice.
Parker RF; Davis JK; Blalock DK; Thorp RB; Simecka JW; Cassell GH
Infect Immun; 1987 Nov; 55(11):2631-5. PubMed ID: 3666955
[TBL] [Abstract][Full Text] [Related]
3. Differences in virulence for mice among strains of Mycoplasma pulmonis.
Davidson MK; Lindsey JR; Parker RF; Tully JG; Cassell GH
Infect Immun; 1988 Aug; 56(8):2156-62. PubMed ID: 3397187
[TBL] [Abstract][Full Text] [Related]
4. Roles of innate and adaptive immunity in respiratory mycoplasmosis.
Cartner SC; Lindsey JR; Gibbs-Erwin J; Cassell GH; Simecka JW
Infect Immun; 1998 Aug; 66(8):3485-91. PubMed ID: 9673224
[TBL] [Abstract][Full Text] [Related]
5. Gene expression and production of tumor necrosis factor alpha, interleukin 1, interleukin 6, and gamma interferon in C3H/HeN and C57BL/6N mice in acute Mycoplasma pulmonis disease.
Faulkner CB; Simecka JW; Davidson MK; Davis JK; Schoeb TR; Lindsey JR; Everson MP
Infect Immun; 1995 Oct; 63(10):4084-90. PubMed ID: 7558323
[TBL] [Abstract][Full Text] [Related]
6. Clearance of different strains of Mycoplasma pulmonis from the respiratory tract of C3H/HeN mice.
Davidson MK; Davis JK; Lindsey JR; Cassell GH
Infect Immun; 1988 Aug; 56(8):2163-8. PubMed ID: 3397188
[TBL] [Abstract][Full Text] [Related]
7. Strain differences in susceptibility to murine respiratory mycoplasmosis in C57BL/6 and C3H/HeN mice.
Davis JK; Parker RF; White H; Dziedzic D; Taylor G; Davidson MK; Cox NR; Cassell GH
Infect Immun; 1985 Dec; 50(3):647-54. PubMed ID: 4066026
[TBL] [Abstract][Full Text] [Related]
8. Short-term exposure to nitrogen dioxide enhances susceptibility to murine respiratory mycoplasmosis and decreases intrapulmonary killing of Mycoplasma pulmonis.
Parker RF; Davis JK; Cassell GH; White H; Dziedzic D; Blalock DK; Thorp RB; Simecka JW
Am Rev Respir Dis; 1989 Aug; 140(2):502-12. PubMed ID: 2504091
[TBL] [Abstract][Full Text] [Related]
9. Immunoglobulin class- and subclass-specific responses to Mycoplasma pulmonis in sera and secretions of naturally infected Sprague-Dawley female rats.
Brown MB; Reyes L
Infect Immun; 1991 Jun; 59(6):2181-5. PubMed ID: 2037378
[TBL] [Abstract][Full Text] [Related]
10. Murine respiratory mycoplasmosis: a model to study effects of oxidants.
Davis JK; Davidson M; Schoeb TR
Res Rep Health Eff Inst; 1991 Dec; (47):1-29; discussion 31-43. PubMed ID: 1838926
[TBL] [Abstract][Full Text] [Related]
11. Depletion of alveolar macrophages exacerbates respiratory mycoplasmosis in mycoplasma-resistant C57BL mice but not mycoplasma-susceptible C3H mice.
Hickman-Davis JM; Michalek SM; Gibbs-Erwin J; Lindsey JR
Infect Immun; 1997 Jun; 65(6):2278-82. PubMed ID: 9169764
[TBL] [Abstract][Full Text] [Related]
12. Genetic control of resistance to Mycoplasma pulmonis infection in mice.
Lai WC; Linton G; Bennett M; Pakes SP
Infect Immun; 1993 Nov; 61(11):4615-21. PubMed ID: 8406858
[TBL] [Abstract][Full Text] [Related]
13. Profiling of cellular immune responses to Mycoplasma pulmonis infection in C57BL/6 and DBA/2 mice.
Boonyarattanasoonthorn T; Elewa YHA; Tag-El-Din-Hassan HT; Morimatsu M; Agui T
Infect Genet Evol; 2019 Sep; 73():55-65. PubMed ID: 31026602
[TBL] [Abstract][Full Text] [Related]
14. Gender is a major factor in determining the severity of mycoplasma respiratory disease in mice.
Yancey AL; Watson HL; Cartner SC; Simecka JW
Infect Immun; 2001 May; 69(5):2865-71. PubMed ID: 11292700
[TBL] [Abstract][Full Text] [Related]
15. Role of upper and lower respiratory tract immunity in resistance to Mycoplasma respiratory disease.
Hodge LM; Simecka JW
J Infect Dis; 2002 Jul; 186(2):290-4. PubMed ID: 12134269
[TBL] [Abstract][Full Text] [Related]
16. Resistance to mycoplasmal lung disease in mice is a complex genetic trait.
Cartner SC; Simecka JW; Briles DE; Cassell GH; Lindsey JR
Infect Immun; 1996 Dec; 64(12):5326-31. PubMed ID: 8945584
[TBL] [Abstract][Full Text] [Related]
17. Role of antibody in the protection of mice from arthritis induced by Mycoplasma pulmonis.
Keystone EC; Cunningham AJ; Metcalfe A; Kennedy M; Quinn PA
Clin Exp Immunol; 1982 Feb; 47(2):253-9. PubMed ID: 7075023
[TBL] [Abstract][Full Text] [Related]
18. Protection of mice against Mycoplasma pulmonis infection using purified mouse immunoglobulins: comparison between protective effect and biological properties of immunoglobulin classes.
Taylor G; Howard CJ
Immunology; 1981 Jul; 43(3):519-25. PubMed ID: 7251063
[TBL] [Abstract][Full Text] [Related]
19. Autoimmune-Disease-Prone NOD Mice Help To Reveal a New Genetic Locus for Reducing Pulmonary Disease Caused by Mycoplasma pulmonis.
Wawegama NK; Markham PF; Elso CM; Kanci A; Marenda MS; Browning GF; Brodnicki TC
Infect Immun; 2018 Mar; 86(3):. PubMed ID: 29263105
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-17A Exacerbates Disease Severity in BALB/c Mice Susceptible to Lung Infection with Mycoplasma pulmonis.
Mize MT; Sun XL; Simecka JW
Infect Immun; 2018 Sep; 86(9):. PubMed ID: 29986888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
